Document is current
Any future updates will be listed below
-
Authors
Zhao, Zhongyuan
Zou, Peng
Fang, Yuan
Si, Tong
Li, Yanyan
Yi, Bofang
Zhang, Tao
-
Funding
Funding for this research was provided by:
Binghamton University School of Pharmacy and Pharmaceutical Sciences
U.S. Food and Drug Administration (75F40123C00208)
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 8 April 2025
First Online: 16 April 2025
Declarations
:
: Author Zou P is an employee of Ultragenyx Pharmaceutical Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: During the preparation of this work the author(s) used Grammarly in order to correct the spelling and grammar mistakes. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
: Not applicable.
: Not applicable.
